주 메뉴 바로가기 본문 바로가기 하단 바로가기
Celltrion Healthcare UK Ltd is not able to provide advice to patients. If you have a question specific to a medical condition, therapy area, or one of our products, please consult with your local healthcare professional.
You can also report to side effects directly via the yellow card scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Or report to Celltrion Healthcare and its authorised commercialisation partners by calling +44 (0) 1279 406759 (Diamond Pharma Services)
Below you will find information on Celltrion Healthcare’s product portfolio. Prescribing information and patient information leaflets for each product can be downloaded through the links. These links direct you to the Electronic Medicines Compendium (eMC); and provide information about all medicines available in the UK.

Remsima® (infliximab)
Remsima® - UK summary of Product Characteristics and Patient information leaflets
https://www.medicines.org.uk/emc/search?q=remsima
CTHC-UK-185A July 2020

Cookie technology helps us bring you the best possible experience when you visit this website. If you continue without changing your settings, you are agreeing to the cookies on this website. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.